« 6TH POPE Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

Re: Study Finds Coronavirus Immunity May Be Fleeting 

By: Beldin in 6TH POPE | Recommend this post (1)
Wed, 15 Jul 20 7:03 PM | 23 view(s)
Boardmark this board | 6th Edition Pope Board
Msg. 03387 of 53267
(This msg. is a reply to 03382 by Decomposed)

Jump:
Jump to board:
Jump to msg. #

"The Chinese got us good."

The ChiCom asswipes manufactured this toxic baby while they were screwin' around with biological warfare agents. They either let it loose intentionally without any care whatsoever for the consequences or they stupidly allowed it to get away from them, inadvertently. Either way, the ChiComs have grimly damaged themselves, as well as the rest of the world. Of course, the ChiCom higher echelons don't give a crap, as long as they do not personally suffer. 




Avatar

The essential American soul is hard, isolate, stoic, and a killer. It has never yet melted. ~ D.H. Lawrence




» You can also:
- - - - -
The above is a reply to the following message:
Study Finds Coronavirus Immunity May Be Fleeting
By: Decomposed
in 6TH POPE
Wed, 15 Jul 20 10:50 AM
Msg. 03382 of 53267

None of you should be surprised by this story. It's confirmation of what I've been saying for months - that people can contract the disease repeatedly because the immunity they gain after a recovery does not last. Specifically, 14% of those who test positive for the antibodies test negative just 3 months later. That suggests herd immunity will never occur and makes it unlikely that any single vaccine is going to eradicate this disease. Maybe if people get booster shots every three months...

The bottom line is that I've invested in possible treatments for those who have COVID-19, not in possible vaccines. And if the markets are boosted by vaccine successes, I'll treat the news as a profit-taking opportunity in unrelated stocks and a buying opportunity in treatment stocks like MESO and PSTI. I'm afraid the disease itself is going to be with us for a very long time. The Chinese got us good.

June 14, 2020

Study Finds Coronavirus Immunity May Be Fleeting

by Rick Moran
PJmedia.com



Several drugmakers are in a race to create a vaccine to combat the coronavirus and it appears that some kind of vaccine will be on the market by the end of summer with large scale production of several vaccines ramping up by early 2021.

CNBC:


The U.S. is aiming to deliver 300 million doses of a vaccine for Covid-19 by early 2021. The manufacturing process is already underway even though they aren’t sure which vaccine, if any, will work, a senior Trump administration official told reporters on a conference call Monday. He said they are already buying equipment, securing the manufacturing sites and, in some cases, acquiring the raw materials.

“Exactly when the vaccine materials will be in production and manufacturing? It’s probably four to six weeks away,” the official said on the call, which was hosted by the Department of Health and Human Services. “But we will be actively manufacturing by the end of the summer.”

No company has ever rushed a vaccine into production in so short a time. What’s more, no one knows which of several vaccines will actually shield people from the virus.

Will they work? More importantly, for how long?

Vaccines create antibodies that allow the body to fight off specific infections. But the bugs can be tricky. The coronavirus family, which includes the common cold, SARS, and MERS, as well as the novel coronavirus affecting us today, can fool the antibodies and avoid destruction. This can lead to yearly infections of COVID-19 as the effectiveness of the vaccine wears off over a period of months.

This is not unusual. Most children need vaccine booster shots for a variety of childhood diseases. But the problem is that we don’t know how long immunity to COVID-19 will last after being vaccinated.

Under normal circumstances, the FDA would require dozens of trials over a period of years to determine how effective a vaccine is over the long haul. But that won’t be the case with COVID-19. And that’s a big question mark.

A study from Kings College in London found that it’s possible that any vaccine developed will create an immunity that only lasts a few months.

Daily Caller:


The study found that 60% of patients developed a “potent” response with antibodies at the peak of their infection with the virus, but only 17% retained the potency three months later. Antibody levels dropped so sharply in some patients that they became undetectable.

“People are producing a reasonable antibody response to the virus, but it’s waning over a short period of time and depending on how high your peak is, that determines how long the antibodies are staying around,” Dr. Katie Doores, lead author on the study, told The Guardian.

Doores also told The Guardian that a vaccine for the virus might also potentially fall short after a few months. “People may need boosting and one shot might not be sufficient,” Doores explained.

This is one study looking at one vaccine — hardly a smoking gun, but added to the body of knowledge we already possess about the way the body responds to the coronavirus. It’s helpful. It gives scientists and researchers currently working at breakneck speed to develop a vaccine another possible avenue of research to explore — never a bad thing.

The first polio vaccine created by Dr. Jonas Salk had an incredible psychological effect on the world. And yet, the Salk vaccine was only 70 percent effective. Gradually over the years, the vaccine improved until today. Now, it is 94 percent effective in combatting polio.

We should expect something similar with a vaccine for the coronavirus. It may take decades to perfect. In the meantime, the widescale distribution of the vaccine will allow us to return to some state of normalcy.

http://pjmedia.com/news-and-politics/rick-moran/2020/07/14/study-finds-coronavirus-immunity-may-be-fleeting-n638768


« 6TH POPE Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next